Today, JAMA published Toward a Healthier Future Through Obesity Prevention and Care: The #JAMASummit Report on Obesity.
🔗 Read the full report: ja.ma/4iWbcvc
#ObesityWeek #OW2026
2
450
Join JAMA and JAMA Network Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, and leading experts in #obesity research, treatment, and policy for an inside look at Toward a Healthier Future: The #JAMASummit Report on Obesity.
➡️ Register now: ja.ma/4klwTak
2
340
From @JAMA_current: Among veterans with stable #CoronaryArteryDisease, upfront #PercutaneousCoronaryIntervention plus optimal medical therapy did not reduce long-term death or myocardial infarction vs optimal medical therapy alone.
ja.ma/4Amo6td
#ScientificSessions26
417
💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients.
ja.ma/4iOF10J
#ScientificSessions26
From @JAMA_current: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy.
ja.ma/4zximwV
#ScientificSessions26
From @JAMACardio: #AI analysis of clinical notes identified infrequent low-density lipoprotein cholesterol target documentation and heterogeneous reasons for nonescalation of #LipidLoweringTherapy in secondary prevention.
ja.ma/4zuXdn0
#ScientificSessions26
1
1
395
💬 Editorial from @JAMA_current: An individualized treatment approach for #ObstructiveSleepApnea may combine weight-reducing therapy with positive airway pressure, oral appliances, or other airway-directed treatments.
ja.ma/4zB70I7
#ScientificSessions26
📊 Research Summary from @JAMA_current: In 2 trials of adults with moderate to severe #ObstructiveSleepApnea and excess weight, oral orforglipron improved sleep-disordered breathing, body weight, and hypoxic burden.
ja.ma/4z7OK88
#ScientificSessions26
3
320
#ScientificSessions26 from @JAMA_current: Oral #Orforglipron improved apnea-hypopnea index, hypoxic burden, and body weight vs placebo in adults with #ObstructiveSleepApnea and obesity or overweight, w/ gastrointestinal adverse events reported more often.
ja.ma/4k72NqS
1
3
287
#ScientificSessions26 from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease.
ja.ma/4j4RAWI
📊 Research Summary: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy.
ja.ma/3WxgIwG
#ScientificSessions26
1
221
📣 Stay connected with the JAMA Network at #ScientificSessions26!
Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4eY16Zp
163
From @JAMA_current: Among veterans with stable #CoronaryArteryDisease, upfront #PercutaneousCoronaryIntervention plus optimal medical therapy did not reduce long-term death or myocardial infarction vs optimal medical therapy alone.
ja.ma/3WzzW4M
#ScientificSessions26
📣 Stay connected with the JAMA Network at #ScientificSessions26!
Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4BUb6wQ
235
💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients.
ja.ma/4ep2QLb
#ScientificSessions26
371
📊 Research Summary from @JAMA_current: Long-term follow-up in #ISCHEMIA-EXTEND indicates no significant all-cause mortality difference between initial invasive and conservative management of stable #CoronaryDisease.
ja.ma/4kEJh59
#ScientificSessions26
358
Presented at #ScientificSessions26 from @JAMA_current: Among patients with stable #CoronaryDisease and moderate or severe ischemia, an initial invasive strategy did not improve long-term survival vs an initial conservative strategy.
ja.ma/4iu7iuq
#ScientificSessions26 from @JAMACardio: #AI analysis of clinical notes identified infrequent low-density lipoprotein cholesterol target documentation and heterogeneous reasons for nonescalation of #LipidLoweringTherapy in secondary prevention.
ja.ma/4zDOuis
1
343
📣 Stay connected with the JAMA Network at #ScientificSessions26!
Explore the latest cardiovascular research, featured articles, editor sessions, and attendee resources from the JAMA Network: ja.ma/4zISsq3
146
💬 Editorial from @JAMA_current: In patients with stable #CoronaryArteryDisease and at least moderate inducible ischemia, long-term follow-up from #ISCHEMIA supports a medical therapy–first approach for most patients.
ja.ma/4iA71F6
#ScientificSessions26




















